SCHEMBL5662944

SCHEMBL5662944

CCOC(COC(C)=O)OCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
LMNA P02545 3/20 0.52
HSD17B10 Q99714 1/20 0.52
TSHR P16473 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.33
GAA P10253 2/20 0.33
CHRM5 P08912 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
ALOX15 P16050 1/20 0.33
THRB P10828 1/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
PGR P06401 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
HTR1A P08908 1/20 0.33
CHRNB2 P17787 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11428709 0.89 TDP1 (0.47) ALDH1A1LMNAHSD17B10TSHRTDP1
SCHEMBL26300306 0.89 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10TSHRTDP1
SCHEMBL10576468 0.88 ALDH1A1 (0.41) ALDH1A1LMNAHSD17B10TSHRTDP1
SCHEMBL215227 0.87 ALDH1A1 (0.53) ALDH1A1LMNAHSD17B10TSHRTDP1
Ethylene Glycol SCHEMBL11201998 0.84 TDP1 (0.43) ALDH1A1LMNAHSD17B10TSHRTDP1
SCHEMBL28122801 0.83 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10TSHRGAA
SCHEMBL12582664 0.81 ALDH1A1 (0.52) ALDH1A1LMNAHSD17B10TSHRTDP1
SCHEMBL28629883 0.81 ALDH1A1 (0.36) ALDH1A1LMNAHSD17B10SMN1; SMN2GAA
SCHEMBL2777851 0.79 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10TSHRTDP1
SCHEMBL6276290 0.79 MGAM (0.54) ALDH1A1LMNAHSD17B10TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118620520-A Polyamide imide varnish cured at low temperature and preparation method and application thereof 宁波博雅聚力新材料科技有限公司 2024-09-10 CN claimed
EP-2134760-B1 COMPOSITION CONTAINING A MODIFIED (POLY)ISOCYANATE AND A SOLVENT OF THE ACETAL OR ALIPHATIC KETONE TYPE, AND USE OF SAID COMPOSITION FOR PRODUCING COATINGS VENCOREX FRANCE (FR) 2018-09-26 EP claimed
CN-101624335-B Preparation method of 2,2-diethoxyethanol and derivative thereof BEIJING LEWEI TAIKE MEDICAL TECHNOLOGY CO LTD 2013-05-08 CN claimed
CN-101624335-A Preparation method of 2,2-diethoxyethanol and derivative thereof BEIJING LEWEI TAIKE MEDICAL TE 2010-01-13 CN claimed
US-4192870-A Novel zootechnical compositions ROUSSEL UCLAF (FR) 1980-03-11 US claimed
CN-117590707-B Preparation method of pixel defining layer DUK SAN NEOLUX CO.,LTD. (KR) 2026-05-26 CN disclosed
US-20250171450-A1 NOVEL COELENTERAZINE DERIVATIVES NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2025-05-29 US disclosed
CN-120051168-A Preparation method of pixel defining layer 德山新勒克斯有限公司 2025-05-27 CN disclosed
CN-120051169-A Preparation method of pixel defining layer 德山新勒克斯有限公司 2025-05-27 CN disclosed
CN-119978994-A Low-temperature cured enameled wire and preparation method thereof 宁波博雅聚力新材料科技有限公司 2025-05-13 CN disclosed
CN-119859263-A Polyimide-based precursor and composition containing same 德山新勒克斯有限公司 2025-04-22 CN disclosed
CN-119859265-A Polybenzoxazole-based or polyimide-based precursor, copolymer thereof, and positive photosensitive composition containing same 德山新勒克斯有限公司 2025-04-22 CN disclosed
WO-2003051298-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD. (BB) 2003-06-26 WO disclosed
US-5399718-A Direct fluorination process for making perfluorinated organic substances MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-03-21 US disclosed
EP-0462840-B1 Material for forming coating film JAPAN SYNTHETIC RUBBER CO LTD (JP) 1995-02-15 EP disclosed
US-5362919-A Direct fluorination process for making perfluorinated organic substances MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1994-11-08 US disclosed
EP-0609200-A1 DIRECT FLUORINATION PROCESS FOR MAKING PERFLUORINATED ORGANIC SUBSTANCES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1994-08-10 EP disclosed
WO-1990006296-A1 DIRECT FLUORINATION PROCESS FOR MAKING PERFLUORINATED ORGANIC SUBSTANCES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-06-14 WO disclosed
EP-0110633-A2 Silver halide photographic light-sensitive material KONICA CORPORATION (JP) 1984-06-13 EP disclosed
US-4192870-A Novel zootechnical compositions ROUSSEL UCLAF (FR) 1980-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171450-A1 NOVEL COELENTERAZINE DERIVATIVES CBR3, CYP4F3, MRPL21 ALDH1A1 1527/4885LMNA 4728/4885HSD17B10 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.